Cargando…

Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing

INTRODUCTION: Vitamin D (VD) deficiency has been associated with multiple sclerosis (MS) and other autoimmune diseases (AIDs). However, the effect of the genetics of VD on the risk of MS is subject to debate. This study focuses on genes linked to the VD signaling pathway in families with MS. The eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Pytel, Vanesa, Matías‐Guiu, Jordi A., Torre‐Fuentes, Laura, Montero‐Escribano, Paloma, Maietta, Paolo, Botet, Javier, Álvarez, Sara, Gómez‐Pinedo, Ulises, Matías‐Guiu, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456803/
https://www.ncbi.nlm.nih.gov/pubmed/30900415
http://dx.doi.org/10.1002/brb3.1272
_version_ 1783409813660631040
author Pytel, Vanesa
Matías‐Guiu, Jordi A.
Torre‐Fuentes, Laura
Montero‐Escribano, Paloma
Maietta, Paolo
Botet, Javier
Álvarez, Sara
Gómez‐Pinedo, Ulises
Matías‐Guiu, Jorge
author_facet Pytel, Vanesa
Matías‐Guiu, Jordi A.
Torre‐Fuentes, Laura
Montero‐Escribano, Paloma
Maietta, Paolo
Botet, Javier
Álvarez, Sara
Gómez‐Pinedo, Ulises
Matías‐Guiu, Jorge
author_sort Pytel, Vanesa
collection PubMed
description INTRODUCTION: Vitamin D (VD) deficiency has been associated with multiple sclerosis (MS) and other autoimmune diseases (AIDs). However, the effect of the genetics of VD on the risk of MS is subject to debate. This study focuses on genes linked to the VD signaling pathway in families with MS. The evaluation of gene variants in all the members of families could contribute to an additional knowledge on the information obtained from case‐control studies that use nonrelated healthy people. MATERIAL AND METHODS: We studied 94 individuals from 15 families including at least two patients with MS. We performed whole‐exome next generation sequencing on all individuals and analyzed variants of the DHCR7, CYP2R1, CYP3A4, CYP27A1, GC, CYP27B1, LRP2, CUBN, DAB2, FCGR, RXR, VDR, CYP24A1, and PDIA3 genes. We also studied PTH, FGF23, METTL1, METTL21B, and the role of the linkage disequilibrium block on the long arm of chromosome 12, through analysis of the CDK4, TSFM, AGAP2, and AVIL genes. We compared patients with MS, other AIDs and unaffected members from different family types. RESULTS: The study described the variants in the VD signaling pathway that appear in families with at least two patients with MS. Some infrequent variants were detected in these families, but no significant difference was observed between patients with MS and/or other AIDs and unaffected family members in the frequency of these variants. Variants previously associated with MS in the literature were not observed in these families or were distributed similarly in patients and unaffected family members. CONCLUSION: The study of genes involved in the VD signaling pathway in families that include more than one patient with MS did not identify any variants that could explain the presence of the disease, suggesting that VD metabolism could probably play a role in MS more as an environmental factor rather than as a genetic factor. Our study also supports the analysis of cases and unaffected individuals within families in order to determine the influence of genetic factors.
format Online
Article
Text
id pubmed-6456803
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64568032019-04-19 Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing Pytel, Vanesa Matías‐Guiu, Jordi A. Torre‐Fuentes, Laura Montero‐Escribano, Paloma Maietta, Paolo Botet, Javier Álvarez, Sara Gómez‐Pinedo, Ulises Matías‐Guiu, Jorge Brain Behav Original Research INTRODUCTION: Vitamin D (VD) deficiency has been associated with multiple sclerosis (MS) and other autoimmune diseases (AIDs). However, the effect of the genetics of VD on the risk of MS is subject to debate. This study focuses on genes linked to the VD signaling pathway in families with MS. The evaluation of gene variants in all the members of families could contribute to an additional knowledge on the information obtained from case‐control studies that use nonrelated healthy people. MATERIAL AND METHODS: We studied 94 individuals from 15 families including at least two patients with MS. We performed whole‐exome next generation sequencing on all individuals and analyzed variants of the DHCR7, CYP2R1, CYP3A4, CYP27A1, GC, CYP27B1, LRP2, CUBN, DAB2, FCGR, RXR, VDR, CYP24A1, and PDIA3 genes. We also studied PTH, FGF23, METTL1, METTL21B, and the role of the linkage disequilibrium block on the long arm of chromosome 12, through analysis of the CDK4, TSFM, AGAP2, and AVIL genes. We compared patients with MS, other AIDs and unaffected members from different family types. RESULTS: The study described the variants in the VD signaling pathway that appear in families with at least two patients with MS. Some infrequent variants were detected in these families, but no significant difference was observed between patients with MS and/or other AIDs and unaffected family members in the frequency of these variants. Variants previously associated with MS in the literature were not observed in these families or were distributed similarly in patients and unaffected family members. CONCLUSION: The study of genes involved in the VD signaling pathway in families that include more than one patient with MS did not identify any variants that could explain the presence of the disease, suggesting that VD metabolism could probably play a role in MS more as an environmental factor rather than as a genetic factor. Our study also supports the analysis of cases and unaffected individuals within families in order to determine the influence of genetic factors. John Wiley and Sons Inc. 2019-03-21 /pmc/articles/PMC6456803/ /pubmed/30900415 http://dx.doi.org/10.1002/brb3.1272 Text en © 2019 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Pytel, Vanesa
Matías‐Guiu, Jordi A.
Torre‐Fuentes, Laura
Montero‐Escribano, Paloma
Maietta, Paolo
Botet, Javier
Álvarez, Sara
Gómez‐Pinedo, Ulises
Matías‐Guiu, Jorge
Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
title Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
title_full Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
title_fullStr Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
title_full_unstemmed Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
title_short Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
title_sort exonic variants of genes related to the vitamin d signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456803/
https://www.ncbi.nlm.nih.gov/pubmed/30900415
http://dx.doi.org/10.1002/brb3.1272
work_keys_str_mv AT pytelvanesa exonicvariantsofgenesrelatedtothevitamindsignalingpathwayinthefamiliesoffamilialmultiplesclerosisusingwholeexomenextgenerationsequencing
AT matiasguiujordia exonicvariantsofgenesrelatedtothevitamindsignalingpathwayinthefamiliesoffamilialmultiplesclerosisusingwholeexomenextgenerationsequencing
AT torrefuenteslaura exonicvariantsofgenesrelatedtothevitamindsignalingpathwayinthefamiliesoffamilialmultiplesclerosisusingwholeexomenextgenerationsequencing
AT monteroescribanopaloma exonicvariantsofgenesrelatedtothevitamindsignalingpathwayinthefamiliesoffamilialmultiplesclerosisusingwholeexomenextgenerationsequencing
AT maiettapaolo exonicvariantsofgenesrelatedtothevitamindsignalingpathwayinthefamiliesoffamilialmultiplesclerosisusingwholeexomenextgenerationsequencing
AT botetjavier exonicvariantsofgenesrelatedtothevitamindsignalingpathwayinthefamiliesoffamilialmultiplesclerosisusingwholeexomenextgenerationsequencing
AT alvarezsara exonicvariantsofgenesrelatedtothevitamindsignalingpathwayinthefamiliesoffamilialmultiplesclerosisusingwholeexomenextgenerationsequencing
AT gomezpinedoulises exonicvariantsofgenesrelatedtothevitamindsignalingpathwayinthefamiliesoffamilialmultiplesclerosisusingwholeexomenextgenerationsequencing
AT matiasguiujorge exonicvariantsofgenesrelatedtothevitamindsignalingpathwayinthefamiliesoffamilialmultiplesclerosisusingwholeexomenextgenerationsequencing